Irinotecan sucrosofate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
149 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 15 | 39 | 11 | — | 4 | 59 |
| Neoplasms | D009369 | — | C80 | 11 | 4 | 1 | — | 1 | 15 |
| Pancreatic ductal carcinoma | D021441 | — | — | 2 | 7 | 1 | — | 1 | 11 |
| Small cell lung carcinoma | D055752 | — | — | 2 | 6 | 1 | — | 1 | 9 |
| Esophageal squamous cell carcinoma | D000077277 | — | — | — | 3 | 1 | — | — | 4 |
| Esophageal neoplasms | D004938 | — | C15 | — | 2 | 1 | — | — | 3 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | — | 1 | — | — | 2 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 9 | 14 | — | — | 1 | 19 |
| Adenocarcinoma | D000230 | — | — | 3 | 10 | — | — | 1 | 11 |
| Biliary tract neoplasms | D001661 | — | C24.9 | 2 | 7 | — | — | 1 | 8 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 3 | 5 | — | — | — | 7 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 4 | — | — | — | 6 |
| Recurrence | D012008 | — | — | 2 | 4 | — | — | — | 5 |
| Carcinoma | D002277 | — | C80.0 | 1 | 4 | — | — | — | 5 |
| Rectal neoplasms | D012004 | — | — | 1 | 3 | — | — | — | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 1 | — | — | — | 3 |
| Gastrointestinal neoplasms | D005770 | — | C26.9 | 2 | 2 | — | — | — | 3 |
Show 34 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Peritoneal neoplasms | D010534 | — | — | 3 | — | — | — | — | 3 |
| Glioma | D005910 | EFO_0000520 | — | 2 | — | — | — | — | 2 |
| Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
| Mucinous cystadenocarcinoma | D018282 | — | — | 1 | — | — | — | — | 1 |
| Mucinous adenocarcinoma | D002288 | — | — | 1 | — | — | — | — | 1 |
| Mesothelioma | D008654 | — | C45 | 1 | — | — | — | — | 1 |
| Pseudomyxoma peritonei | D011553 | EFO_0007456 | — | 1 | — | — | — | — | 1 |
| And serous mucinous cystic neoplasms | D018297 | — | — | 1 | — | — | — | — | 1 |
| Wasting syndrome | D019282 | — | — | 1 | — | — | — | — | 1 |
| Weight loss | D015431 | — | — | 1 | — | — | — | — | 1 |
Show 10 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Irinotecan sucrosofate |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
23 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use